Hotaling Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,384
Closed -$1.85M 126
2022
Q1
$1.85M Sell
3,384
-151
-4% -$79.4K 0.71% 48
2021
Q4
$2.33M Buy
3,535
+34
+1% +$21.3K 0.81% 43
2021
Q3
$2.18M Buy
3,501
+11
+0.3% +$7.39K 0.9% 41
2021
Q2
$2.2M Sell
3,490
-33
-0.9% -$18.2K 0.9% 41
2021
Q1
$1.72M Sell
3,523
-2
-0.1% -$1K 0.77% 44
2020
Q4
$1.76M Sell
3,525
-18
-0.5% -$8.05K 0.82% 44
2020
Q3
$1.39M Sell
3,543
-19
-0.5% -$7.03K 0.75% 46
2020
Q2
$1.18M Sell
3,562
-129
-3% -$37.4K 0.68% 51
2020
Q1
$894K Sell
3,691
-223
-6% -$58.2K 0.67% 54
2019
Q4
$1.02M Buy
3,914
+60
+2% +$15.8K 0.59% 61
2019
Q3
$1.05M Sell
3,854
-134
-3% -$37.3K 0.67% 56
2019
Q2
$1.1M Buy
3,988
+2,952
+285% +$727K 0.71% 54
2019
Q1
$232K Buy
+1,036
New +$214K 0.16% 108

Other funds holding IDXX

Hotaling Investment Management's IDXX Position: Q2 2022 in Review

Hotaling Investment Management sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 3,384 shares — an estimated $1.85M sold.

Hotaling Investment Management first reported a position in IDXX in Q1 2019 and held it in 13 quarters. The position peaked at $2.33M in Q4 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Hotaling Investment Management reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
  • Hotaling Investment Management sold 3,384 Idexx Laboratories shares in Q2 2022, an estimated $1.85M.
  • Hotaling Investment Management first reported a position in Idexx Laboratories in Q1 2019 and held it in 13 quarters.
  • Hotaling Investment Management's Idexx Laboratories position peaked at $2.33M in Q4 2021.
  • 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Hotaling Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.